BiotechTube
Home/Alteron Therapeutics/Chengliang Zhang
CZ

Chengliang Zhang

Chief Executive Officer

Alteron Therapeutics

Therapeutic Areas

NeurologyRare DiseasesPulmonology

Alteron Therapeutics Pipeline

DrugIndicationPhase
ALTA-808Amyotrophic Lateral Sclerosis (ALS)Preclinical
ALTA Drug SeriesAlzheimer's DiseasePreclinical

Leadership Team at Alteron Therapeutics

CF
Chandler Fang
Co-Founder
TS
Trish Sinnott
Investor Relations
BM
Biao Ma
Scientist
View full Alteron Therapeutics profile